Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like Nickel Price Update: Q2 2025 in Review July 29, 2025 Lithium Market 2025 Year-End Review December 23, 2025 Finlay Minerals Announces Closing of Non-Brokered Private Placement... June 10, 2025 Canadian Investment Regulatory Organization Trade Resumption – PRIZ July 19, 2025 Scoping Study Demonstrates Low Cost ISR Uranium Potential June 5, 2025 Beyond HODL: Why the DeFi Technologies Lawsuit Signals... January 2, 2026 ALTECH – CERENERGY Battery Prototype Reaches Key Milestones September 12, 2025 Editor’s Picks: Gold Price Sets Sights on US$3,900,... October 4, 2025 Red Mountain Mining Successfully Lists on the US... November 19, 2025 Mali Court Seizes Control of Barrick Gold Mine... June 20, 2025